Highlights GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:23 2024-12-09 EST			5-day change	1st Jan Change
1,383.00 ^GBX	+2.90%		+3.09%	-4.63%

08:44pm	GSK highlights positive Blenrep data from Dreamm-7 trial	AN
08:27pm	GSK Reports Positive Results in Phase 3 Trial for Refractory Multiple Myeloma Treatment	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK highlights positive Blenrep data from Dreamm-7 trial	02:44pm	AN
GSK Reports Positive Results in Phase 3 Trial for Refractory Multiple Myeloma Treatment	02:27pm	MT
GSK Gets Positive Results in Blood-Cancer Drug Trial	01:45pm	DJ
GSK's Blenrep Combination Therapy for Multiple Myeloma Gets Priority Review in China	11:10am	MT
AlphaValue/Baader Europe Lifts CureVac FY24 Outlook	06:31am	MT
GSK Wins US, Chinese Nod for Regulatory Reviews of Lung Disease, Multiple Myeloma Treatments	05:02am	MT
GSK's Nucala and Blenrep receive regulatory boost in US and China	03:48am	AN
Boohoo gets ISS backing amid Frasers Group spat	02:52am	AN
GSK's Lung Disease Treatment Application Accepted for Review in US	02:28am	MT
GSK's Application for Blenrep Combination Therapy Accepted in China for Priority Review	02:27am	MT
GSK plc Announces Blenrep Combination China Filing Acceptance	02:05am	CI
Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement	12:28am	MT
Glaxosmithkline in collaboration with Muna Therapeutics on Alzheimer's disease	12-06	FW
GSK: revises agreement with Zhifei for Shingrix in China	12-05	CF
GSK expands Chinese shingles vaccine collaboration with Zhifei	12-05	AN
GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034	12-05	DJ
GSK to Amend, Extend Shingles Vaccine Partnership with Zhifei in China	12-05	MT
GSK expands deal with China's Zhifei to explore RSV vaccine collaboration	12-05	RE
GSK plc and Zhifei Biological Products, Ltd Revise and Extend Strategic Vaccine Collaboration in China	12-05	CI
GSK Partners With Rgenta Therapeutics to Develop Small Molecule Splice Modulators	12-04	MT
GSK's Tafenoquine Gains WHO Prequalification for P. Vivax Malaria	12-04	MT
Rgenta Therapeutics Announces Strategic Alliance with GSK to Develop RNA-Targeted Small Molecule Splice Modulators	12-04	CI
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	12-03	MT
Berenberg Lowers Price Target on GSK to GBP16 From GBP18.20, Maintains Buy Rating	12-02	MT
Wall Street hit by turkey coma	11-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK PLC : Investor disappointment as vaccines again come up short, despite the Q3 beat

October 30, 2024 at 10:26 am

Emma Walmsley, CEO of GSK: Antimicrobial resistance, a public health issue

July 16, 2024 at 08:19 am

GSK plc : Back on track

May 03, 2024 at 05:17 am